SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Kemper Robert – ‘3’ for 4/28/05 re: SPSS Inc.

On:  Thursday, 4/28/05, at 1:30pm ET   ·   For:  4/28/05   ·   As:  Officer   ·   Accession #:  1209191-5-22582   ·   File #:  0-22194

Previous ‘3’:  None   ·   Next & Latest:  ‘3/A’ on 11/28/05 for 4/28/05

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/28/05  Kemper Robert                     3          Officer     2:10K  SPSS Inc.                         DONNELLEY FIN… File16/FA

Initial Statement of Beneficial Ownership of Securities by an Insider   —   Form 3   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 3           Form 3 Submission -- doc3.xml/2.2                   HTML      7K 
 2: EX-24.3_82824  POA Document                                        2±     9K 


‘3’   —   Form 3 Submission — doc3.xml/2.2




        

This ‘3’ Document is an XML Data File that may be rendered in various formats:

  Form 3    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
SEC Info rendering:  Form 3 Submission
 
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Kemper Robert

(Last)(First)(Middle)
SPSS INC.
233 SOUTH WACKER DRIVE, 11TH FLOOR

(Street)
CHICAGOIL60606

(City)(State)(Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
4/28/05
3. Issuer Name and Ticker or Trading Symbol
SPSS INC [ SPSS ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
XOfficer (give title below) Other (specify below)
SVP - Research and Development
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $0.01 par value866D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy) 12/18/03 (1) 12/17/12Common Stock10,00014.43D
Employee Stock Option (Right to Buy) 12/17/03 (2) 12/16/13Common Stock10,00017.25D
Employee Stock Option (Right to Buy) 7/12/05 (1) 7/11/14Common Stock32,00015.97D
Explanation of Responses:
(1)  These options are subject to a four-year vesting schedule, under which 25% of the total option will become exercisable on the first anniversary of the Grant Date, an additional 2.09% of the number of shares originally covered by the option will become exercisable on the first day following the conclusion of each month in the second, third and fourth years following the Grant Date (other than the final month of the fourth year following the Grant Date); and an additional 1.85% of the number of shares originally covered by the option will become exercisable on the first day following the conclusion of the final month of the fourth year following the Grant Date.
(2)  These options are subject to the following vesting schedule: (i) 35.45% of the total option became exercisable on the Grant Date and (ii) an additional 2.09% of the number of shares originally covered by the option will become exercisable on the first day following the conclusion of each month thereafter in the first, second and third years following the Grant Date, until fully vested.
Remarks:
/s/ Anthony Ciro, by Power of Attorney attached hereto 4/28/05
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Top
Filing Submission 0001209191-05-022582   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 9, 6:58:59.1pm ET